1. P-191Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-panitumumab in first-line (BEYOND). (2nd July 2019) Authors: Aparicio, J; Virgili, A; Capdevila, J; Muñoz Boza, F; Álvarez, R; Bosch, C; Cámara, J; Fernandez-Martos, C; Fernandez-Plana, J; Gallego, J; Gallego, R; Hernández-Yagüe, X; Macías Declara, I; Rodríguez-Salas, N; Vera, R; Taberner, M; Maurel, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial. Issue 6 (May 2017) Authors: Pineda, Estela; Salud, A; Vila-Navarro, E; Safont, MJ; Llorente, Beatriz; Aparicio, J; Vera, R; Escudero, P; Casado, E; Bosch, C; Bohn, U; Pérez-Carrión, R; Carmona, A; Ayuso, JR; Ripollés, T; Bouzas, R; Gironella, M; García-Albéniz, X; Feliu, J; Maurel, J Journal: Tumor biology Issue: Volume 39:Issue 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4CPS-031 Therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion: PK/PD target achievement and clinical outcomes. Issue 1 (23rd March 2023) Authors: Fresan, D; Luque, S; Miedes, J; Bosch, C; Benítez-Cano, A; Sorlí, L; De-Antonio, M; Prim, N; Vega, V; Horcajada, JP; Grau, S Journal: European journal of hospital pharmacy Issue: Volume 30:Issue 1(2023)supplement 1 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗